Next Article in Journal
The Role of Cyclic Nucleotide Signaling Pathways in Cancer: Targets for Prevention and Treatment
Next Article in Special Issue
MicroRNAs in the Regulation of MMPs and Metastasis
Previous Article in Journal / Special Issue
Matrix Metalloproteinases: The Gene Expression Signatures of Head and Neck Cancer Progression
Cancers 2014, 6(1), 416-435; doi:10.3390/cancers6010416

Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression

1 Department of Pharmaceutical Sciences, College of Pharmacy, The University of Oklahoma, 1110 North Stonewall Avenue, Oklahoma City, OK 73117, USA 2 Departments of Chemistry and Biology, Torrey Pines Institute for Molecular Studies, Port St. Lucie, FL 34987, USA
* Author to whom correspondence should be addressed.
Received: 25 December 2013 / Revised: 7 February 2014 / Accepted: 8 February 2014 / Published: 17 February 2014
(This article belongs to the Special Issue Matrix Metalloproteinases in Cancer Progress)
View Full-Text   |   Download PDF [1017 KB, uploaded 17 February 2014]   |   Browse Figures


Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a zinc-dependent type-I transmembrane metalloproteinase involved in pericellular proteolysis, migration and invasion. Numerous substrates and binding partners have been identified for MT1-MMP, and its role in collagenolysis appears crucial for tumor invasion. However, development of MT1-MMP inhibitors must consider the substantial functions of MT1-MMP in normal physiology and disease prevention. The present review examines the plethora of MT1-MMP activities, how these activities relate to cancer initiation and progression, and how they can be monitored in real time. Examination of MT1-MMP activities and cell surface behaviors can set the stage for the development of unique, selective MT1-MMP inhibitors.
Keywords: MT1-MMP; MMP-14; matrix metalloproteinases; CD44; collagen; metastasis MT1-MMP; MMP-14; matrix metalloproteinases; CD44; collagen; metastasis
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Pahwa, S.; Stawikowski, M.J.; Fields, G.B. Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression. Cancers 2014, 6, 416-435.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert